2017. Adalimumab for Nail Psoriasis: Efficacy and Safety from the Open-Label Extension of a Phase-3, Randomized, Placebo-Controlled Trial. SKIN The Journal of Cutaneous Medicine. 1, 3.1 (Oct. 2017), s97. DOI:https://doi.org/10.25251/skin.1.supp.96.